National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons.
about
Optimizing adjuvant therapy and survivorship care of stage III colon cancer.Disease burden and pain in obese cancer patients with chemotherapy-induced peripheral neuropathyRandomized controlled trial of neurofeedback on chemotherapy-induced peripheral neuropathy: A pilot studyAstragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy?Preventing oxaliplatin-induced neurotoxicity: rationale and design of phase Ib randomized, double-blind, placebo-controlled, cross-over trials for early clinical evaluation of investigational therapeutics.Chemotherapy-induced peripheral neuropathy: A current review.A Mechanistic Understanding of Axon Degeneration in Chemotherapy-Induced Peripheral Neuropathy.Nicotine prevents and reverses paclitaxel-induced mechanical allodynia in a mouse model of CIPN.Characterization of a rat model of bortezomib-induced painful neuropathy.Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy.Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial.Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer.Gaps in Understanding Mechanism and Lack of Treatments: Potential Use of a Nonhuman Primate Model of Oxaliplatin-Induced Neuropathic Pain.Evoked and Ongoing Pain-Like Behaviours in a Rat Model of Paclitaxel-Induced Peripheral Neuropathy.
P2860
Q30249616-9F92139B-0A2E-41CA-BFF1-8C355191D111Q33711656-4606442F-59DD-43CF-951B-5B9846752DB3Q33796889-A526F3A7-E08A-435A-8AC6-EAFEAFB10269Q37634989-BD41CCA1-D7B0-45F0-9C33-6DAB03FDCC4BQ38931361-C3175D6B-E063-4BE2-AFB5-E20F208CEF97Q39293928-ACC46F33-D8E8-43CE-83D7-614A6E0ED65CQ41606031-8377B0F5-5CBA-44EC-AEF3-FA787DC42C89Q45070329-A0A1E199-4C9A-451E-B7B4-738EB3A77EB5Q47120603-468C3684-FA4C-4FD3-81FA-B02955603459Q47552411-2FD727D4-FEA7-4F02-BB60-F4B5A41BF6C5Q47564629-D99EC1ED-87BF-493D-93AA-F25300802D5FQ52610762-2510722B-F677-4737-8F09-E05C113FF995Q55109090-10299B7F-77E0-4EF9-810A-9C4B77098AF6Q55364011-091368B1-9CED-4B93-B37F-2F7414C6BE05Q55411583-71D4A610-D978-4365-8779-6AB0FE332B6E
P2860
National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 December 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
National Cancer Institute-supp ...... trials: outcomes and lessons.
@en
National Cancer Institute-supp ...... trials: outcomes and lessons.
@nl
type
label
National Cancer Institute-supp ...... trials: outcomes and lessons.
@en
National Cancer Institute-supp ...... trials: outcomes and lessons.
@nl
prefLabel
National Cancer Institute-supp ...... trials: outcomes and lessons.
@en
National Cancer Institute-supp ...... trials: outcomes and lessons.
@nl
P2093
P2860
P1476
National Cancer Institute-supp ...... trials: outcomes and lessons.
@en
P2093
Andreas S Beutler
Charles L Loprinzi
Kathryn J Ruddy
Neil Majithia
Sarah M Temkin
P2860
P2888
P304
P356
10.1007/S00520-015-3063-4
P577
2015-12-19T00:00:00Z